Bcl-xL Cancer Research Results
Bcl-xL, Bcl-xL: Click to Expand ⟱
| Source: |
| Type: pro-survival proteins |
The proteins of BCL-2 family are classified into three subgroups, i.e., the anti-apoptotic/pro-survival proteins represented by BCL-2 and BCL-XL.
BCL-XL overexpressing cells exhibited higher tumors sphere formation capacity and expressed higher levels of some stem cell markers, supporting the concept that BCL-XL plays essential roles in the maintenance of cancer stem cell phenotype.
|
HCC, Hepatocellular Carcinoma: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
HCC, |
Bel-7402 |
|
|
|
Apoptosis↑, TumAuto↑, P-gp↓, Bcl-xL↓, ChemoSen↑,
ChemoSen↑, TumCP↓, TumCCA↑, TumCMig↓, TumCI↓, MMPs↓, MAPK↓, TGF-β↓, ZFX↓, p‑MEK↓, ERK↓, MMP2↓, MMP9↓, uPA↓, TIMP1↓, TIMP2↓, NF-kB↓, p65↓, p‑IKKα↓, Fas↑, Casp2↑, Casp3↑, Casp8↑, Casp9↑, Bcl-xL↓, BAX↑, ER Stress↑, Ca+2↑, JNK↑, P53↑, ROS↑, H2O2↑, cMyc↓, CD24↓, 12LOX↓,
| - |
vitro+vivo, |
HCC, |
HepG2 |
|
|
|
- |
in-vitro, |
HCC, |
Hep3B |
|
|
|
- |
in-vitro, |
HCC, |
HUH7 |
|
|
|
STAT3↓, Akt↓, cSrc↓, JAK1↓, JAK2↓, SHP1↑, cycD1/CCND1↓, Bcl-2↓, Bcl-xL↓, Mcl-1↓, survivin↓, VEGF↓, TumCP↓, Casp3↑, cl‑PARP↑, ChemoSen↑, XIAP↓,
| - |
vitro+vivo, |
HCC, |
HepG2 |
|
|
|
- |
vitro+vivo, |
Liver, |
HUH7 |
|
|
|
STAT3↓, TumCP↓, cycD1/CCND1↓, Bcl-2↓, Bcl-xL↓, Mcl-1↓, survivin↓, VEGF↓, TumCCA↑, TumVol↓,
Showing Research Papers: 1 to 4 of 4
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 4
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
H2O2↑, 1, ROS↑, 1,
Mitochondria & Bioenergetics ⓘ
p‑MEK↓, 1, XIAP↓, 1,
Core Metabolism/Glycolysis ⓘ
12LOX↓, 1, cMyc↓, 1,
Cell Death ⓘ
Akt↓, 1, Apoptosis↑, 1, BAX↑, 1, Bcl-2↓, 2, Bcl-xL↓, 4, Casp2↑, 1, Casp3↑, 2, Casp8↑, 1, Casp9↑, 1, Fas↑, 1, JNK↑, 1, MAPK↓, 1, Mcl-1↓, 2, survivin↓, 2,
Kinase & Signal Transduction ⓘ
cSrc↓, 1,
Protein Folding & ER Stress ⓘ
ER Stress↑, 1,
Autophagy & Lysosomes ⓘ
TumAuto↑, 1,
DNA Damage & Repair ⓘ
P53↑, 1, cl‑PARP↑, 1,
Cell Cycle & Senescence ⓘ
cycD1/CCND1↓, 2, TumCCA↑, 2,
Proliferation, Differentiation & Cell State ⓘ
CD24↓, 1, ERK↓, 1, SHP1↑, 1, STAT3↓, 2, ZFX↓, 1,
Migration ⓘ
Ca+2↑, 1, MMP2↓, 1, MMP9↓, 1, MMPs↓, 1, TGF-β↓, 1, TIMP1↓, 1, TIMP2↓, 1, TumCI↓, 1, TumCMig↓, 1, TumCP↓, 3, uPA↓, 1,
Angiogenesis & Vasculature ⓘ
VEGF↓, 2,
Barriers & Transport ⓘ
P-gp↓, 1,
Immune & Inflammatory Signaling ⓘ
p‑IKKα↓, 1, JAK1↓, 1, JAK2↓, 1, NF-kB↓, 1, p65↓, 1,
Drug Metabolism & Resistance ⓘ
ChemoSen↑, 3,
Functional Outcomes ⓘ
TumVol↓, 1,
Total Targets: 52
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: Bcl-xL, Bcl-xL
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:10 Cells:% prod#:% Target#:28 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page